• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小儿用米诺卡霉素。皮埃蒙特和瓦莱达奥斯塔多中心研究结果]

[Miocamycin in pediatrics. Results of multicenter study in Piedmont and Valle d'Aosta].

作者信息

De Sario P N, Bianco R, De Marco A, Gavioli F, Orecchia L, Salvadori G, Stradoni P

机构信息

Ospedale Maria Vittoria di Torino, Divisione di Pediatria.

出版信息

Ann Osp Maria Vittoria Torino. 1986 Jul-Dec;29(7-12):317-28.

PMID:3329481
Abstract

A multicenter clinical trial has been fulfilled by 18 Paediatric Hospital Centers in the regions of Piedmont and Aosta Valley, on 139 cases, concerning the use of a new macrolide, miocamycin, in the therapy of various infective diseases, such as upper and lower respiratory tract infections, ear and nose, throat, teeth affections, minor surgery, some contagious diseases. The results of this trial show a good effectiveness of the drug, consisting in a rapid disappearance of the clinical symptoms, a high degree of systemic and gastroenteric tolerability, and very poor side effects.

摘要

皮埃蒙特和奥斯塔山谷地区的18家儿科医院中心对139例病例进行了一项多中心临床试验,该试验涉及一种新型大环内酯类药物——米卡霉素在多种感染性疾病治疗中的应用,这些疾病包括上、下呼吸道感染、耳鼻喉及牙齿疾病、小型手术以及一些传染病。该试验结果显示,该药疗效良好,临床症状迅速消失,全身及胃肠道耐受性高,且副作用极小。

相似文献

1
[Miocamycin in pediatrics. Results of multicenter study in Piedmont and Valle d'Aosta].[小儿用米诺卡霉素。皮埃蒙特和瓦莱达奥斯塔多中心研究结果]
Ann Osp Maria Vittoria Torino. 1986 Jul-Dec;29(7-12):317-28.
2
[Miocamycin: multicenter clinical study in patients with bacterial infections of the upper respiratory tract].[米欧卡霉素:上呼吸道细菌感染患者的多中心临床研究]
G Ital Chemioter. 1987 Jan-Dec;34(1-3):63-71.
3
[Clinical use of midecamycin. Apropos of 60 cases].麦迪霉素的临床应用。附60例报告
G Ital Chemioter. 1977 Jan-Dec;24(1-2):63-5.
4
Clinical experience with miocamycin in the treatment of respiratory tract infections.
Drugs Exp Clin Res. 1985;11(4):263-8.
5
[Miocamycin in the therapy of bacterial infections in childhood].[米欧卡霉素用于儿童细菌感染的治疗]
Clin Ter. 1988 Apr 30;125(2):107-13.
6
[Multicenter study of the clinical efficacy and tolerance of roxithromicin compared to doxycycline in lower respiratory infections].
Pathol Biol (Paris). 1988 May;36(5):548-51.
7
[Clinical study of a new macrolide, miocamycin, in 150 patients with otorhinolaryngologic disorders].新型大环内酯类药物米卡霉素治疗150例耳鼻喉科疾病患者的临床研究
Clin Ter. 1987 Jul 15;122(1):13-6.
8
[Macroral: clinical study for evaluating efficacy and tolerance of miocamycin in infections in odontostomatology].[大剂量口服:米卡霉素治疗口腔颌面部感染的疗效及耐受性临床研究]
Minerva Stomatol. 1989 May;38(5):519-22.
9
[Clinical and bacteriological evaluation of miocamycin in some respiratory tract infections].[米卡霉素在某些呼吸道感染中的临床及细菌学评价]
Riv Eur Sci Med Farmacol. 1987 Sep;9(3):323-5.
10
[Use of Enramycin in pediatrics].[恩拉霉素在儿科的应用]
Minerva Pediatr. 1973 Feb 18;25(5):210-3.

引用本文的文献

1
Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age.用于预防5岁以下儿童未分化急性呼吸道感染化脓性并发症的抗生素。
Cochrane Database Syst Rev. 2016 Feb 29;2(2):CD007880. doi: 10.1002/14651858.CD007880.pub3.